Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

ACRO leads the way forward in CTTI

Association Of Clinical Research Organizations : 07 May, 2008  (Company News)
The Association of Clinical Research Organizations (ACRO), which represents the clinical outsourcing industry to regulators, biopharmaceutical clients, policymakers, and the public in the USA and worldwide, is taking a leadership role in the recently formed Clinical Trial Transformation Initiative (CTTI).
The goal of the CTTI is to modernise the mechanics of clinical trials and to increase their efficiency and productivity.

The CTTI was established by the US FDA in collaboration with Duke University as part of the FDA's Critical Path Initiative. Alberto Grignolo, PhD, corporate vice president and General Manager of Parexel Consulting, a business unit of Parexel International, will represent the association on the CTTI Executive Board, which is comprised of experts from the FDA, National Institutes of Health (NIH), academia, biopharmaceutical companies, CROs, and other organizations.

'ACRO is excited to be a part of this important effort to further enhance the clinical trial process,' said ACRO executive director Doug Peddicord, PhD. 'We are pleased to have an industry leader like Dr Grignolo participating on behalf of the association to share the CRO perspective and the expertise of our members with the consortium.'

'CTTI has an important charge as it looks to establish models for clinical trial innovation in areas such as study design, operating procedures, and metrics for evaluation,' said Dr Grignolo. 'I look forward to representing the CRO industry and working with the wide range of stakeholders involved to help make this initiative successful for all who participate in the clinical trial enterprise, including study participants, investigators, regulators, sponsors, and CROs.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo